https://pharmadog.xyz/news/416844 pharmadog en 2026-09-17T15:28:07.000Z Michael J. Fox Foundation backs Ariadne Bio's non-hallucinogenic psychedelic for Parkinson's https://pharmadog.xyz/news/416867 pharmadog en 2026-09-17T15:21:34.000Z Novo Nordisk signs up to $1.4 billion deal with Orbis Medicines to develop oral macrocycle cardiometabolic drugs https://pharmadog.xyz/news/416845 pharmadog en 2026-09-17T15:17:40.000Z CMS launches 10-year ACCESS health-tech pilot for Medicare https://pharmadog.xyz/news/416907 pharmadog en 2026-09-17T15:09:00.000Z North Immunology to go public via reverse merger with Aethlon, targeting eczema market https://pharmadog.xyz/news/416611 pharmadog en 2026-09-17T14:57:41.000Z Kennedy appoints eight specialists to U.S. Preventive Services Task Force, ending year-long vacancy https://pharmadog.xyz/news/416567 pharmadog en 2026-09-17T14:52:34.000Z Endpoints 11 reveals 2026’s most promising biotech startups at Boston gala https://pharmadog.xyz/news/416568 pharmadog en 2026-09-17T14:34:00.000Z Roche's Lunsumio clears Phase 3 hurdle, paving way for broader label in indolent lymphoma https://pharmadog.xyz/news/416612 pharmadog en 2026-09-17T14:30:37.000Z Startup launches trial of psychedelic-style drug for Parkinson’s symptom https://pharmadog.xyz/news/416613 pharmadog en 2026-09-17T14:17:03.000Z FDA staffing shortage limits ability to hire new employees, raising concerns for health-care oversight https://pharmadog.xyz/news/416614 pharmadog en 2026-09-17T14:11:18.000Z Study finds purer fentanyl will not curb U.S. overdose deaths https://pharmadog.xyz/news/416591 pharmadog en 2026-09-17T14:01:44.000Z Webinar Explores Manufacturing Risks and Partner Strategies for the Next Five Years https://pharmadog.xyz/news/416443 pharmadog en 2026-09-17T13:42:03.000Z Biotech sector expected to weather Fed rate hike despite higher capital costs https://pharmadog.xyz/news/416444 pharmadog en 2026-09-17T13:39:53.000Z Novartis' $12B Avidity deal falters as DM1 therapy misses Phase 3 endpoint https://pharmadog.xyz/news/416419 pharmadog en 2026-09-17T13:11:09.000Z General Catalyst outlines tech collaborations with Summa Health after hospital acquisition https://pharmadog.xyz/news/416615 pharmadog en 2026-09-17T13:09:13.000Z Zocdoc adds chatbot scheduling and updates on Medicare ACCESS https://pharmadog.xyz/news/416276 pharmadog en 2026-09-17T12:19:58.000Z Longeveron shares plunge 57% after stem-cell therapy fails in mid-stage heart trial https://pharmadog.xyz/news/416277 pharmadog en 2026-09-17T12:13:55.000Z Roche commits up to $1 billion to develop bispecific antibodies with Dualitas https://pharmadog.xyz/news/416127 pharmadog en 2026-09-17T11:59:57.000Z FDA hiring delays persist despite expectations, and Bavarian Nordic names new CEO https://pharmadog.xyz/news/416083 pharmadog en 2026-09-17T11:15:40.000Z Bavarian Nordic appoints former Sanofi, AstraZeneca and Pfizer executive Tarja Stenvall as CEO https://pharmadog.xyz/news/416084 pharmadog en 2026-09-17T11:00:05.000Z Orbis Medicines signs up to $1.4 billion partnership with Novo to develop macrocycle drugs for cardiometabolic disease https://pharmadog.xyz/news/415959 pharmadog en 2026-09-17T10:30:00.000Z Biotech hedge fund launches North Immunology to develop long-acting antibody for atopic dermatitis https://pharmadog.xyz/news/415960 pharmadog en 2026-09-17T10:30:00.000Z Sellas’ Phase 3 REGAL AML Immunotherapy Study Delayed, Forecast to Miss Survival Endpoint https://pharmadog.xyz/news/415939 pharmadog en 2026-09-17T10:13:23.000Z Experts discuss wet AMD treatment limits and need for longer lasting therapies https://pharmadog.xyz/news/416542 pharmadog en 2026-09-17T10:02:00.000Z Lisata Therapeutics merges with Marea Therapeutics in reverse merger after failed Kuva deal https://pharmadog.xyz/news/415703 pharmadog en 2026-09-17T10:00:00.000Z Roche partners with Dualitas Therapeutics in up to $1 billion deal to screen bispecific antibodies for immune diseases https://pharmadog.xyz/news/415515 pharmadog en 2026-09-17T08:30:00.000Z FDA hiring drive to add 2,000 staff stalls due to overwhelmed HR center https://pharmadog.xyz/news/415516 pharmadog en 2026-09-17T08:30:00.000Z Shift away from oppositional defiant disorder reflects changing views on child noncompliance https://pharmadog.xyz/news/416228 pharmadog en 2026-09-17T08:07:00.000Z Roche inks $1 billion deal with Dualitas to screen 300,000 bispecific combos for immunology and inflammation https://pharmadog.xyz/news/416398 pharmadog en 2026-09-17T07:43:00.000Z North Immunology to go public via reverse merger, targeting eczema with bispecific antibody https://pharmadog.xyz/news/415347 pharmadog en 2026-09-17T07:42:48.000Z England's NHS to fund AstraZeneca's Enhertu for metastatic breast cancer after U.K.-U.S. pricing pact https://pharmadog.xyz/news/415327 pharmadog en 2026-09-17T07:00:00.000Z Biopharma hiring surges in Massachusetts and California, with science/R&D and clinical roles leading demand https://pharmadog.xyz/news/415328 pharmadog en 2026-09-17T07:00:00.000Z Over 15,000 Science/R&D jobs and 10,800 Clinical roles posted on BioSpace in first eight months of 2026 https://pharmadog.xyz/news/416059 pharmadog en 2026-09-17T06:27:00.000Z SK Biopharma signs $315 million deal with 1ST Biotherapeutics for preclinical Parkinson’s drug 1ST-104 https://pharmadog.xyz/news/415890 pharmadog en 2026-09-17T04:12:00.000Z Longeveron’s pediatric heart stem-cell trial misses primary endpoint, prompting cost cuts https://pharmadog.xyz/news/414063 pharmadog en 2026-09-17T00:39:34.000Z Researchers sue NIH over grant screening that they say violates First Amendment rights https://pharmadog.xyz/news/416227 pharmadog en 2026-09-16T21:40:00.000Z 'Still a bull': Novo's CEO on honoring heritage and planning for the future amid corporate rebrand https://pharmadog.xyz/news/413235 pharmadog en 2026-09-16T20:20:15.000Z GOP Bill Seeks to Tilt Medicare Advantage Study Toward Insurers https://pharmadog.xyz/news/413087 pharmadog en 2026-09-16T19:17:40.000Z Senators probe nominee Chris Klomp’s influence on HHS health-policy and drug pricing https://pharmadog.xyz/news/412807 pharmadog en 2026-09-16T18:30:48.000Z Five major drugmakers cooperate with House investigation of Chinese military hospital trials https://pharmadog.xyz/news/412639 pharmadog en 2026-09-16T17:19:15.000Z Yale and Harvard faculty question benefits of FDA's 'America First' user fee provisions https://pharmadog.xyz/news/412575 pharmadog en 2026-09-16T16:29:10.000Z WHO sees declining Ebola transmission in DRC but warns months of work remain https://pharmadog.xyz/news/412363 pharmadog en 2026-09-16T15:37:33.000Z Gilead signs HIV PrEP partnership with PAHO in Latin America https://pharmadog.xyz/news/412319 pharmadog en 2026-09-16T15:10:00.000Z Novo Nordisk partners with Anthropic to boost drug discovery using Claude Science AI https://pharmadog.xyz/news/412172 pharmadog en 2026-09-16T15:00:26.000Z Stanford researchers create mice with human neurons to advance disease studies https://pharmadog.xyz/news/412216 pharmadog en 2026-09-16T15:00:00.000Z Stanford researchers create mice with half human brain tissue using cerebral organoids https://pharmadog.xyz/news/134233 pharmadog en 2026-09-16T14:41:00.000Z CLINUVEL to cut up to 20% of staff and move headquarters to New York https://pharmadog.xyz/news/412197 pharmadog en 2026-09-16T14:28:29.000Z FDA issues warning letter to Bausch & Lomb over aseptic processing concerns https://pharmadog.xyz/news/412198 pharmadog en 2026-09-16T14:24:26.000Z Psychedelic therapeutics near first FDA approval as Compass Pathways and Definium report promising results https://pharmadog.xyz/news/412173 pharmadog en 2026-09-16T14:10:28.000Z Novo and Anthropic partner to test Claude Science AI platform in drug discovery R&D https://pharmadog.xyz/news/412023 pharmadog en 2026-09-16T13:41:09.000Z Novartis stops ALS TREM2 stabilizer after Phase 2 miss, marking fourth trial setback in a month https://pharmadog.xyz/news/412043 pharmadog en 2026-09-16T13:34:04.000Z Sen. Warren calls for release of Trump-era pharma pricing contracts amid accusations against RFK Jr. https://pharmadog.xyz/news/412044 pharmadog en 2026-09-16T13:29:12.000Z FDA opens applications for pilot program to speed up first-in-human testing https://pharmadog.xyz/news/412469 pharmadog en 2026-09-16T13:05:57.000Z Skyhawk reports functional gains in Huntington's disease trial of RNA-splicing pill https://pharmadog.xyz/news/411895 pharmadog en 2026-09-16T12:30:34.000Z Sling Therapeutics raises $123M Series C to advance oral thyroid eye disease drug https://pharmadog.xyz/news/411767 pharmadog en 2026-09-16T11:56:12.000Z U.S. sees highest number of measles deaths in decades as outbreak spreads to 693 cases https://pharmadog.xyz/news/123087 pharmadog en 2026-09-16T11:49:00.000Z BioSpace launches dashboard to track performance of U.S. biotech IPOs in 2026 https://pharmadog.xyz/news/411703 pharmadog en 2026-09-16T11:24:04.000Z Novartis scraps TREM2 ALS candidate after Phase 2 failure https://pharmadog.xyz/news/411595 pharmadog en 2026-09-16T11:00:19.000Z Sling Therapeutics raises $123M to fund Phase 3 trial of former Astellas cancer drug for thyroid eye disease https://pharmadog.xyz/news/411596 pharmadog en 2026-09-16T10:56:58.000Z Skyhawk Therapeutics reports symptom improvement for Huntington's disease in Phase 1/2 extension study https://pharmadog.xyz/news/412122 pharmadog en 2026-09-16T10:28:00.000Z Novartis halts ALS drug VHB937 after phase 2 trial fails to meet endpoints https://pharmadog.xyz/news/411363 pharmadog en 2026-09-16T10:02:08.000Z FDA holds psychedelic forum as Definium reports third successful Phase 3 trial of oral LSD for anxiety https://pharmadog.xyz/news/416060 pharmadog en 2026-09-16T08:54:00.000Z Novo signs $1.4 billion deal with Orbis Medicines to develop oral macrocycle cardiometabolic drugs https://pharmadog.xyz/news/411954 pharmadog en 2026-09-16T08:32:00.000Z Novartis pays $125 million to acquire Sironax’s brain-delivery platform https://pharmadog.xyz/news/411257 pharmadog en 2026-09-16T08:30:00.000Z Dementia should be a campaign issue, not a political insult, says expert https://pharmadog.xyz/news/411256 pharmadog en 2026-09-16T08:30:00.000Z Professor uses his own thymic cancer journey to teach medical students about real-world oncology https://pharmadog.xyz/news/411255 pharmadog en 2026-09-16T08:30:00.000Z Democrats pledge to use oversight powers to push health-care reforms if they win Congress https://pharmadog.xyz/news/410960 pharmadog en 2026-09-16T07:00:00.000Z Biopharma workers increasingly postpone retirement, poll shows 52% plan to stay longer https://pharmadog.xyz/news/410959 pharmadog en 2026-09-16T07:00:00.000Z Biotech firms race to hire AI-savvy scientists as talent gap widens https://pharmadog.xyz/news/410575 pharmadog en 2026-09-16T05:00:00.000Z Biotech firms increase product launches as capital markets improve https://pharmadog.xyz/news/414262 pharmadog en 2026-09-16T00:00:00.000Z Experts urge more representative enrollment in clinical trials https://pharmadog.xyz/news/414261 pharmadog en 2026-09-16T00:00:00.000Z Experts assess EU medical device and diagnostic regulations at RAPS Convergence 2026 https://pharmadog.xyz/news/409315 pharmadog en 2026-09-15T21:13:00.000Z FDA approves first generic radioligand therapy for neuroendocrine tumors as Sionna announces major layoffs https://pharmadog.xyz/news/409837 pharmadog en 2026-09-15T20:31:00.000Z Danone USA recalls So Delicious Dairy Free Salted Caramel Cluster frozen dessert pints over possible foreign material https://pharmadog.xyz/news/408892 pharmadog en 2026-09-15T18:45:31.000Z HHS nominee Chris Klomp faces questioning from Sen. Elizabeth Warren on voluntary drug‑pricing contracts https://pharmadog.xyz/news/408936 pharmadog en 2026-09-15T18:43:59.000Z Fourth measles death reported in Pennsylvania, all victims unvaccinated https://pharmadog.xyz/news/408591 pharmadog en 2026-09-15T16:59:15.000Z FDA approves first radioligand generic, pitting Curium against Novartis' Lutathera